Theoretically, it might be that after all these experiments, cells with the CD44+/CD133+/ITGA6+/CD36+ signature can indeed be described as a phenotype especially characteristic of stem‐like glioblastoma cells. The gene discussed is CD44; the disease is glioblastoma.